This phase II trial tests whether the combination of nivolumab and ipilimumab is better than nivolumab alone to shrink tumors in patients with deficient mismat…

Endometrial AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Dedifferentiated Carcinoma+6 more

~Estimated

~$10 – $5,625

National Cancer Institute (NCI)NCT05112601

Phase 1

Phase 1 Clinical Trial of ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer

Endometrial cancer (EC) is the fourth most common cancer in United States women, and alarmingly, the frequency and mortality from EC continues to rise, in part…

Endometrial CancerMetastasisEndometrioid Endometrial Cancer+5 more

~Estimated

~$10 – $6,250

UNC Lineberger Comprehensive Cancer CenterNCT05542407